The Hydration Pharmaceuticals Company Limited (ASX:HPC)

ASX:HPC Revenue

The Hydration Pharmaceuticals Company had revenue of $1.53M USD in the half year ending June 30, 2025, a decrease of -71.24%. This brings the company's revenue in the last twelve months to $2.93M, up 14.89% year-over-year. In the year 2024, The Hydration Pharmaceuticals Company had annual revenue of $3.20M, down -25.48%.

• Revenue (ttm): $2.93M
• Revenue Growth: +14.89%
• P/S Ratio: 0.48
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.15M AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.20M	-1.10M	-25.48%
Dec 31, 2023	4.30M	-4.80M	-52.74%
Dec 31, 2022	9.10M	2.97M	48.52%
Dec 31, 2021	6.13M	2.37M	63.10%
Dec 31, 2020	3.76M	793.87K	26.79%